We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Method Quickly Identifies Antibiotic-Resistant Acinetobacter

By HospiMedica staff writers
Posted on 11 Dec 2007
Acinetobacter baumannii, a bacterium widely found on our skin and in the environment, has now become a major threat in hospitals where it can cause serious infections, such as pneumonia in severely ill patients. More...
The new types Acinetobacter are resistant to nearly all antibiotics and three resistant strains are currently circulating in the United Kingdom. A molecular method for identifying the bacteria has been successfully developed.

The method, designed by the Health Protection Agency (London, UK), was successfully implemented by medical scientists at the Royal Free Hospital (Hampstead, UK). It is a quick and accurate means of identifying which strain of the bacterium is infecting a patient. The multiplex-polymerase chain reaction (PCR), based on identifying unique gene sequences in the bacteria, has the potential to be developed as a rapid screening tool for intensive care units in other parts of the country. It should eventually lead to better patient management with faster and more appropriate treatments for individuals and prompt control of infections to reduce the risk of transmission to other patients

The drug-resistant strains of the bacteria are especially dangerous in intensive care units where, as well as causing pneumonia, they can infect wounds, or cause urinary tract infections. "Some of these new strains of A. baumannii, known as epidemic clones, can spread rapidly and widely between patients and have the potential to cause outbreaks,” said Kerry Williams of the Royal Free Hospital. "We currently encounter two of them at our hospital, so we need a reliable and rapid means of identifying and discriminating between the different clones. We can now get a result from a patient's sample in just four hours. The test also allows us to predict how likely we are to be facing an outbreak.”

"Like MRSA, A. baumannii can be found on the skin without actually causing an infection. The new test is important because it means we can rapidly identify patients who are colonized with drug-resistant strains of the bacteria so that special infection control measures can be put in place. The patient can quickly be isolated if necessary,” added Miss Williams of the Royal Free Hospital. "This reduces the risk of transmission to other patients and the possibility of an outbreak occurring. The ability to distinguish between the clones circulating is also important because it allows us to monitor transmission in our hospital.”

Currently all the Royal Free Hospital strains of bacteria are sent to a reference laboratory for typing by a method called pulsed field gel electrophoresis. The new test, called multiplex-PCR, gives results comparable to the ones produced by the reference laboratory.

The method was described at the Federation of Infection Societies Conference 2007 in Cardiff (Wales,UK), on November 28, 2007.


Related Links:
Health Protection Agency
Royal Free Hospital

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.